Bilirubin conjugate is a stable, water-soluble ditaurate derivative of bilirubin meant to mimic endogenous bilirubin glucuronide derivatives. In vivo, bilirubin circulates in the plasma and is taken up by hepatocytes and conjugated to one or two glucuronic acids in a reaction catalyzed by UDP glucuronidase to form bilirubin mono or diglucuronide. This water-soluble form is then excreted from the liver in bile in the feces or is converted to urobilinogen and excreted in the urine. In addition to aiding in the disposal of heme, bilirubin and its conjugated derivatives have been shown to exhibit anti-oxidant and antimutagenic effects and to play a role in gut barrier function.
AV-153 is a 1,4-dihydropyridine derivative with antimutagenic properties. It intercalates into DNA at single strand breaks, resulting in reduced DNA damage and stimulation of DNA repair in human cells in vitro. AV-153 also interacts with thymine and cytosine and influences poly(ADP)ribosylation. Moreover, AV-153 exhibits anti-cancer activity.
9,10-Dichlorostearic acid is a chlorinated stearic acid that possesses antimutagenic properties. In vitro studies show that this compound induces membrane damage in mammalian tumor cells by causing leakage of adenosine triphosphate (ATP).
AV-153 free base 是一种 1,4-二氢吡啶(1,4-DHP) 衍生物。AV-153 free base 是一种抗诱变剂,具有抗癌活性。AV-153 free base 可以与胞嘧啶和胸腺嘧啶相互作用,并影响聚 (ADP) 核糖基化。在体外实验中,AV-153 free base 在 DNA 的单链断裂处插入到 DNA 并减少 DNA 损伤,刺激 DNA 修复。